Download PDF
CC BY-NC-ND 4.0 · Journal of Gastrointestinal and Abdominal Radiology 2022; 05(01): 058-062
DOI: 10.1055/s-0041-1731975
Case Report

A Case Series of Budd–Chiari Syndrome in Nigerian Patients: Diagnosis, Associations, Management, and Outcomes

Hammed Ninalowo
1   Interventional Radiology, IRDOC Interventional Radiology Consulting Limited, Euracare Multispecialty Hospital, Victoria Island, Lagos, Nigeria
,
Aderemi Oluyemi
2   Department of Gastroenterology, Endoscopy and Hepatology, ReMay Consultancy and Medical Services, Ikeja, Lagos State, Nigeria
,
Omodele Olowoyeye
3   Department of Radiodiagnosis, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria
,
Abisoye Ajayi
3   Department of Radiodiagnosis, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Budd–Chiari syndrome (BCS) is defined as hepatic outflow obstruction regardless of the cause or level of obstruction—from small hepatic veins to the opening of the inferior vena cava in the right atrium. BCS could be primary or secondary. Very few cases of this syndrome have been reported in Nigeria and there is no local clinical series documenting the noninvasive and invasive imaging findings and importance of interventional radiology techniques in its diagnosis and management.

We report three cases of patients diagnosed with BCS in Lagos, Nigeria. We hope this work will raise awareness about the condition and its associations and show that much can be done to establish diagnosis and care with minimally invasive techniques in our resource-limited environment.

Keywords

Budd–Chiari syndrome - Nigeria - interventional radiology - transjugular intrahepatic postosystemic stent-shunt - venoplasty


Publication History

Article published online:
04 October 2021

© 2021. Indian Society of Gastrointestinal and Abdominal Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. European Group for the Study of Vascular Disorders of the Liver. Budd–Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38 (03) 364-371
    CrossrefPubMedGoogle Scholar
  • 2 DeLeve LD, Valla DC, Garcia-Tsao G. American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009; 49 (05) 1729-1764
    CrossrefPubMedGoogle Scholar
  • 3 Seijo S, Plessier A, Hoekstra J. et al. European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57 (05) 1962-1968
    CrossrefPubMedGoogle Scholar
  • 4 Li Y, De Stefano V, Li H. et al. Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2019; 43 (04) 468-474
    CrossrefPubMedGoogle Scholar
  • 5 Kooffreh-Ada M, Chukwudike E, Kajogbola G, Eghwubare F, Okonkwo U, Ngim O. Budd Chiari syndrome: an unexpected diagnosis in a gastroenterology practice in Calabar, Nigeria. Glob J Pure Appl Sci 2019; 25: 103-107
    CrossrefGoogle Scholar
  • 6 Shah SP, Sandhu R, Mitchell S, Larkin G. Visual loss precluding acute onset of Budd–Chiari syndrome. Eye (Lond 2006; 20 (09) 1097-1099
    CrossrefPubMedGoogle Scholar
  • 7 BusinessWireIndia. Fortis Hospital Noida performs India’s first living donor liver transplant, on a Nigerian patient suffering from Budd–Chiari Syndrome (BCS) with fully obstructed inferior vena cava (IVC). Accessed July 6, 2020 at: https://www.businesswireindia.com/fortis-hospital-noida-performs-india's-first-living-donor-liver-transplant-on-a-nigerian-patient-suffering-from-budd-chiari-syndrome-bcs-with-fully-obstructed-inferior-vena-cava-ivc-43000.html.
  • 8 Goel RM, Johnston EL, Patel KV, Wong T. Budd-Chiari syndrome: investigation, treatment and outcomes. Postgrad Med J 2015; 91 (10/82) 692-697
    CrossrefPubMedGoogle Scholar
  • 9 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J 2015; 3 (06) 489-500
    CrossrefPubMedGoogle Scholar
  • 10 Bolondi L, Gaiani S, Li Bassi S. et al. Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology 1991; 100 (05) Pt 1 1324-1331
    CrossrefPubMedGoogle Scholar
  • 11 De BK, De KK, Sen S. et al. Etiology based prevalence of Budd-Chiari syndrome in eastern India. J Assoc Physicians India 2000; 48 (08) 800-803
    PubMedGoogle Scholar
  • 12 Dang X, Li L, Xu P. Research status of Budd-Chiari syndrome in China. Int J Clin Exp Med 2014; 7 (12) 4646-4652
    PubMedGoogle Scholar
  • 13 Plessier A, Sibert A, Consigny Y. et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44 (05) 1308-1316
    CrossrefPubMedGoogle Scholar
  • 14 MacNicholas R, Olliff S, Elias E, Tripathi D. An update on the diagnosis and management of Budd-Chiari syndrome. Expert Rev Gastroenterol Hepatol 2012; 6 (06) 731-744
    CrossrefPubMedGoogle Scholar
  • 15 Darwish Murad S, Valla DC, de Groen PC. et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology 2004; 39 (02) 500-508
    CrossrefPubMedGoogle Scholar